SCHEMBL6580847

SCHEMBL6580847

COc1ccc(-c2nc(-c3cccc(C=O)c3)n(C)n2)cc1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP2 O95551 2/20 0.44
HSD17B2 P37059 1/20 0.44
PSEN1 P49768 3/20 0.43
PSEN2 P49810 3/20 0.43
APH1B Q8WW43 3/20 0.43
NCSTN Q92542 3/20 0.43
APH1A Q96BI3 3/20 0.43
PSENEN Q9NZ42 3/20 0.43
NPC1 O15118 5/20 0.41
RAB9A P51151 5/20 0.41
ALDH1A1 P00352 5/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PDGFRB P09619 1/20 0.40
PDGFRA P16234 1/20 0.40
LMNA P02545 2/20 0.40
MAPT P10636 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6578166 0.83 HSD17B2 (0.51) TDP2HSD17B2PSEN1PSEN2APH1B
SCHEMBL6580839 0.83 KDM4C (0.49) TDP2HSD17B2PSEN1PSEN2APH1B
SCHEMBL6581144 0.80 NR1H2 (0.53) TDP2HSD17B2NPC1RAB9AALDH1A1
SCHEMBL6581048 0.79 HTR7 (0.46) TDP2HSD17B2PSEN1PSEN2APH1B
SCHEMBL6581289 0.77 DRD1 (0.46) TDP2HSD17B2PSEN1PSEN2APH1B
Pyrrolidine SCHEMBL6582654 0.76 KDM4C (0.43) HSD17B2PSEN1PSEN2APH1BNCSTN
SCHEMBL30514362 0.71 ALDH1A1 (0.65) ALDH1A1SMN1; SMN2LMNAMAPTERN1
SCHEMBL4937479 0.71 ALDH1A1 (0.65) ALDH1A1SMN1; SMN2LMNAMAPTERN1
SCHEMBL6584148 0.71 NR1H3 (0.48) NPC1RAB9AALDH1A1SMN1; SMN2NR1H2
SCHEMBL6581365 0.71 NR1H3 (0.43) NPC1RAB9ANR1H2NR1H3TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1070708-B1 Triazole derivatives HOFFMANN LA ROCHE (CH) 2004-01-14 EP disclosed
US-6265426-B1 CENTRAL NERVOUS SYSTEM DISORDERS HOFFMANN-LA ROCHE INC. 2001-07-24 US disclosed
EP-1070708-A1 Triazole and imidazole derivatives F. HOFFMANN-LA ROCHE AG (CH) 2001-01-24 EP disclosed